Literature DB >> 9925249

Secondary neutron and photon dose in proton therapy.

S Agosteo1, C Birattari, M Caravaggio, M Silari, G Tosi.   

Abstract

BACKGROUND AND
PURPOSE: The dose due to secondary neutrons and photons in proton therapy was estimated with Monte Carlo simulations. Three existing facilities treating eye and deep-seated tumours were taken into account. The results of the calculations related to eye proton therapy were verified with measurements.
MATERIALS AND METHODS: The simulations were performed with the FLUKA code. Neutron fluence was measured inside an Alderson phantom (type ART) with activation techniques.
RESULTS: The maximum dose due to secondaries produced in a passive beam delivery system was estimated to be of the order of 10(-4) and 10(-2) Gy per therapy Gy for eye and deep tumour treatments, respectively. In the case of irradiations of deep-seated tumours carried out with an active system, the dose was of the order of 10(-3) Gy per therapy Gy.
CONCLUSIONS: The dose due to secondaries depends on the geometry of the beam delivery system and on the energy of the primary beam and is lower in the healthy tissues distant from the target volume.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9925249     DOI: 10.1016/s0167-8140(98)00049-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  28 in total

1.  Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation.

Authors:  Phillip J Taddei; Anita Mahajan; Dragan Mirkovic; Rui Zhang; Annelise Giebeler; David Kornguth; Mark Harvey; Shiao Woo; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.

Authors:  Phillip J Taddei; Rebecca M Howell; Sunil Krishnan; Sarah B Scarboro; Dragan Mirkovic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

3.  An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy.

Authors:  Rui Zhang; Angélica Pérez-Andújar; Jonas D Fontenot; Phillip J Taddei; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

4.  Assessment of out-of-field absorbed dose and equivalent dose in proton fields.

Authors:  Ben Clasie; Andrew Wroe; Hanne Kooy; Nicolas Depauw; Jay Flanz; Harald Paganetti; Anatoly Rosenfeld
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

5.  Contribution to Neutron Fluence and Neutron Absorbed Dose from Double Scattering Proton Therapy System Components.

Authors:  A Pérez-Andújar; W D Newhauser; P M Deluca
Journal:  Nucl Technol       Date:  2009-01-01

6.  Evaluation of energy deposition and secondary particle production in proton therapy of brain using a slab head phantom.

Authors:  Sayyed Bijan Jia; Mohammad Hadi Hadizadeh; Ali Asghar Mowlavi; Mahdy Ebrahimi Loushab
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-01

7.  Microdosimetric measurements for neutron-absorbed dose determination during proton therapy.

Authors:  Angélica Pérez-Andújar; Paul M Deluca; Allan F Thornton; Markus Fitzek; Draik Hecksel; Jonathan Farr
Journal:  Radiat Prot Dosimetry       Date:  2012-02-14       Impact factor: 0.972

8.  Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.

Authors:  Angélica Pérez-Andújar; Wayne D Newhauser; Paul M Deluca
Journal:  Phys Med Biol       Date:  2009-01-16       Impact factor: 3.609

9.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

10.  Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault.

Authors:  Yuanshui Zheng; Wayne Newhauser; Eric Klein; Daniel Low
Journal:  Phys Med Biol       Date:  2009-11-04       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.